478 results on '"Gurevich, Eugenia V."'
Search Results
152. Each receptor molecule binds its own arrestin
153. In Vivo Gene Silencing by Virally Delivered MicroRNA.
154. Design of Super-arrestins for Gene Therapy of Diseases Associated with Excessive Signaling of G Protein-Coupled Receptors.
155. Ontogeny of the dopamine D2 receptor mRNA expressing cells in the human hippocampal formation and temporal neocortex
156. Dopamine D3 receptor is selectively and transiently expressed in the developing whisker barrel cortex of the rat
157. Dopamine D2 receptor mRNA is expressed in maturing neurons of the human hippocampal and subicular fields
158. Alterations in the cortical serotonergic system in schizophrenia: A postmortem study
159. Limbic circuits and monoamine receptors: Dissecting the effects of antipsy chotics from disease processes
160. Mesolimbic Dopamine D3 Receptors and Use of Antipsychotics in Patients With Schizophrenia
161. Dopamine D2 receptor mRNA expression in the hippocampal formation of schizophrenics
162. Cortex and serotonin in schizophrenia: Effects of antipsychotic treatment?
163. Bulbectomy-induced loss of raphe neurons is counteracted bt antidepressant treatment
164. Antidepressants suppress bulbectomy-induced augmentation of voluntary alcohol consumption in C57Bl/6j but not in DBA/2j mice
165. Effects of bulbectomy and subsequent antidepressant treatment on brain 5-HT2 and 5-HT1A receptors in mice
166. Dissociation of multiple behavioral effects between olfactory bulbectomized C57B1/6J and DBA/2J mice
167. Targeted deletion of one or two copies of the G protein β subunit Gβ5 gene has distinct effects on body weight and behavior in mice.
168. Altered expression and subcellular distribution of GRK subtypes in the dopamine-depleted rat basal ganglia is not normalized byl-DOPA treatment.
169. Cone arrestin binding to JNK3 and Mdm2: conformational preference and localization of interaction sites.
170. Dopamine depletion and subsequent treatment withl-DOPA, but not the long-lived dopamine agonist pergolide, enhances activity of the Akt pathway in the rat striatum.
171. Each rhodopsin molecule binds its own arrestin.
172. Arrestin2.
173. Dopamine D3 receptor is selectively and transiently expressed in the developing whisker barrel cortex of the rat.
174. Receptor–enzyme complex structures show how receptors start to switch off
175. D3 Receptors and the Actions of Neuroleptics in the Ventral Striatopallidal System of Schizophrenics.
176. Cognitive effects of dopamine depletion in the context of diminished acetylcholine signaling capacity in mice
177. Distribution of Dopamine D3 Receptor Expressing Neurons in the Human Forebrain: Comparison with D2 Receptor Expressing Neurons.
178. Comparison of [3H]Paroxetine and [3H]Cyanoimipramine for Quantitative Measurement of Serotonin Transporter Sites in Human Brain.
179. Designer adhesion GPCR tells its signaling story
180. Dopamine D3receptor is selectively and transiently expressed in the developing whisker barrel cortex of the rat
181. Developmental Regulation of Expression of the D3Dopamine Receptor in Rat Nucleus Accumbens and Islands of Calleja1
182. D3Receptors and the Actions of Neuroleptics in the Ventral Striatopallidal System of Schizophrenics
183. GRKs as Modulators of Neurotransmitter Receptors.
184. Distribution of Dopamine D3Receptor Expressing Neurons in the Human Forebrain: Comparison with D2Receptor Expressing Neurons
185. Comparison of [3H]Paroxetine and [3H]Cyanoimipramine for Quantitative Measurement of Serotonin Transporter Sites in Human Brain
186. Structural basis of GPCR coupling to distinct signal transducers: implications for biased signaling.
187. Arrestin‐3 binds parkin and enhances parkin‐dependent mitophagy.
188. GPCR Binding and JNK3 Activation by Arrestin-3 Have Different Structural Requirements.
189. Thalamo-cortical Afferents Control Transient Expression of the Dopamine D[sub 3] Receptor in the Rat Somatosensory Cortex.
190. Effects of bulbectomy and subsequent antidepressant treatment on brain 5-HT 2 and 5-HT 1A receptors in mice
191. The Role of Arrestin-1 Middle Loop in Rhodopsin Binding.
192. Short Arrestin-3-Derived Peptides Activate JNK3 in Cells.
193. Biological Role of Arrestin-1 Oligomerization.
194. Mdm2 enhances ligase activity of parkin and facilitates mitophagy.
195. Cleavage of arrestin-3 by caspases attenuates cell death by precluding arrestin-dependent JNK activation.
196. Non-visual arrestins regulate the focal adhesion formation via small GTPases RhoA and Rac1 independently of GPCRs.
197. Arrestin-2 and arrestin-3 differentially modulate locomotor responses and sensitization to amphetamine.
198. G Protein-coupled Receptor Kinases of the GRK4 Protein Subfamily Phosphorylate Inactive G Protein-coupled Receptors (GPCRs).
199. Overexpression of GRK6 rescues l-DOPA-induced signaling abnormalities in the dopamine-depleted striatum of hemiparkinsonian rats.
200. Arrestin-3 Binds c-Jun N-terminal Kinase 1 (JNK1) and JNK2 and Facilitates the Activation of These Ubiquitous JNK Isoforms in Cells via Scaffolding.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.